Skip to content

Development of a Personalized Cognitive Training Program for Cognitive Impairment in the Elderly and Multicenter Intervention Validation

Development of a Personalized Cognitive Training Program for Cognitive Impairment in the Elderly and Multicenter Intervention Validation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127292
Enrollment
Unknown
Registered
2026-06-29
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

Rule-based Cognitive Training Group:Rule-based Cognitive Training
Al-based Cognitive Training Group:Al-based Cognitive Training

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Inpatients or outpatients aged 50–90 years; 2.Patients diagnosed with amnestic mild cognitive impairment (aMCI) due to AD or mild dementia due to AD, based on the 2018 NIA-AA clinical diagnostic criteria established by the National Institute on Aging and the Alzheimer’s Association; 3.Neuropsychological assessment showing MMSE scores between 18 and 26, and a CDR score of 0.5 or 1; 4.Able to communicate fluently in Chinese (non-illiterate); 5.For those currently receiving cholinesterase inhibitor therapy (e.g., donepezil or rivastigmine), the treatment dose must be stable, defined as a fixed dosage administered continuously for at least six weeks, with no adjustment of the medication regimen during the study period; 6.Provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1.Documented history of cerebrovascular stroke, with clear neurological deficits at onset and corresponding responsible lesions on neuroimaging; 2.Moderate to severe white matter lesions (Fazekas score 3–6); 3.Presence of any cause of consciousness disorder; 4.Severe aphasia or motor disability that prevents completion of neuropsychological assessments; 5.Current psychiatric disorders; 6.History of alcohol dependence, drug addiction, traumatic brain injury, epilepsy, encephalitis, normal-pressure hydrocephalus, or other neurological disorders that may cause cognitive impairment; 7.Systemic diseases that may contribute to mild cognitive impairment (e.g., hepatic or renal insufficiency, endocrine disorders, vitamin deficiencies); 8.Considered unsuitable for participation by the investigators.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA) score;

Secondary

MeasureTime frame
Mini-Mental State Examination (MMSE) score;Activities of Daily Living (ADL) score;Clinical Dementia Rating (CDR) score;

Countries

China

Contacts

Public ContactYu Yueyi

Xuanwu Hospital Capital Medical University

yuyueyi@xwhosp.org+86 10 83198193

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026